AU2003241987A1 - Medicinal composition for treatment for digestive tract disease - Google Patents

Medicinal composition for treatment for digestive tract disease

Info

Publication number
AU2003241987A1
AU2003241987A1 AU2003241987A AU2003241987A AU2003241987A1 AU 2003241987 A1 AU2003241987 A1 AU 2003241987A1 AU 2003241987 A AU2003241987 A AU 2003241987A AU 2003241987 A AU2003241987 A AU 2003241987A AU 2003241987 A1 AU2003241987 A1 AU 2003241987A1
Authority
AU
Australia
Prior art keywords
treatment
digestive tract
medicinal composition
tract disease
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241987A
Inventor
Masaki Hashimoto
Kazuyoshi Takahashi
Youji Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of AU2003241987A1 publication Critical patent/AU2003241987A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003241987A 2002-05-31 2003-05-30 Medicinal composition for treatment for digestive tract disease Abandoned AU2003241987A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002160188A JP2005343791A (en) 2002-05-31 2002-05-31 Medicinal composition for treating digestive tract disease
JP2002-160188 2002-05-31
PCT/JP2003/006845 WO2003101489A1 (en) 2002-05-31 2003-05-30 Medicinal composition for treatment for digestive tract disease

Publications (1)

Publication Number Publication Date
AU2003241987A1 true AU2003241987A1 (en) 2003-12-19

Family

ID=29706537

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241987A Abandoned AU2003241987A1 (en) 2002-05-31 2003-05-30 Medicinal composition for treatment for digestive tract disease

Country Status (3)

Country Link
JP (1) JP2005343791A (en)
AU (1) AU2003241987A1 (en)
WO (1) WO2003101489A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912303D0 (en) * 1989-05-27 1989-07-12 Pfizer Ltd Therapeutic agents
ZA972038B (en) * 1996-03-11 1997-09-17 Ajinomoto Kk 5, 11-dihydrobenzo[b,e][1,4]oxazepine derivatives and pharmaceutical composition containing the same.
KR20010023878A (en) * 1997-09-10 2001-03-26 에가시라 구니오 5,11-Dihydrodibenzo[b,e][1,4]oxazepine derivatives and medicinal composition containing the same
EP1471060A1 (en) * 1999-01-08 2004-10-27 Ajinomoto Co., Inc. 5,11-Dihydrodibenzo[b,e][1,4]-oxazepine derivatives as calcium channel antagonists
WO2001017980A1 (en) * 1999-09-03 2001-03-15 Ajinomoto Co., Inc. Novel processes for preparing oxazepine derivatives
WO2002096891A1 (en) * 2001-05-30 2002-12-05 Ajinomoto Co.,Inc. Dihydrodiaryloxazepine derivative and medicinal composition containing the derivative

Also Published As

Publication number Publication date
WO2003101489A1 (en) 2003-12-11
JP2005343791A (en) 2005-12-15

Similar Documents

Publication Publication Date Title
AU2003299934A1 (en) Implantable digestive tract organ
AU2003270903A1 (en) A video game for assisting healing of the human body
EP1556010A4 (en) Pharmaceutical formulations targeting specific regions of the gastrointestinal tract
AU2001247615A1 (en) Intracorporeal medicaments for photodynamic treatment of disease
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU2001276860A1 (en) Medicaments for chemotherapeutic treatment of disease
AU2003252738A1 (en) Remedy for intestinal diseases and visceral pain
AU2003225372A1 (en) Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases
AU2003243439A1 (en) Medical device for intra-lumenal delivery of pharmaceutical agents
AU2003236156A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
AU2002217316A1 (en) Use of terpenes for the treatment of digestive tract infections
AU2000265525A1 (en) Medicament for treating intestinal diseases
AU2003221078A1 (en) Therapeutic composition for bone infectious disease
AU2002338303A1 (en) Therapeutic compositions for the treatment of a respiratory tract disease
AU2002322263A1 (en) Eglin c based drugs for treatment of disease
AU2003210266A1 (en) Treatment, diagnosis and imaging of disease
AU2003300192A1 (en) Sequences diagnostic for foot and mouth disease
AU2003298719A1 (en) Treatment for sma disease
AU2003223780A1 (en) Treatment for pompe disease
AU2003241987A1 (en) Medicinal composition for treatment for digestive tract disease
AU2003264954A1 (en) Pharmaceutical composition for prevention and treatment of kidney diseases
AU2003274649A1 (en) Diagnostic markers for therapeutic treatment
AU2001271026A1 (en) Remedies for bone diseases
AU2003252479A1 (en) Remedies for respiratory diseases
AU2003281757A1 (en) Ingestible material for the treatment of disease in the human digestive system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase